[HTML][HTML] Treatment with prophylactic oral anticoagulants and the risk of mortality in COVID-19 patients: a nationwide cohort study
S Altaraihi, P Kamstrup, J Eklöf… - ERJ Open …, 2023 - Eur Respiratory Soc
Background Venous thromboembolism has been reported in patients with coronavirus
disease 2019 (COVID-19). It remains unclear if premorbid use of prophylactic oral …
disease 2019 (COVID-19). It remains unclear if premorbid use of prophylactic oral …
Treatment with prophylactic oral anticoagulants and the risk of mortality in COVID-19 patients: a nationwide cohort study
S Altaraihi, P Kamstrup, J Eklöf… - ERJ Open …, 2023 - europepmc.org
Background Venous thromboembolism has been reported in patients with coronavirus
disease 2019 (COVID-19). It remains unclear if premorbid use of prophylactic oral …
disease 2019 (COVID-19). It remains unclear if premorbid use of prophylactic oral …
[HTML][HTML] Treatment with prophylactic oral anticoagulants and the risk of mortality in COVID-19 patients: a nationwide cohort study
S Altaraihi, P Kamstrup, J Eklöf, ND Johansen… - ERJ Open …, 2023 - ncbi.nlm.nih.gov
Background Venous thromboembolism has been reported in patients with coronavirus
disease 2019 (COVID-19). It remains unclear if premorbid use of prophylactic oral …
disease 2019 (COVID-19). It remains unclear if premorbid use of prophylactic oral …
Treatment with prophylactic oral anticoagulants and the risk of mortality in COVID-19 patients; a nationwide cohort study
S Altaraihi, P Kamstrup, J Eklöf, J Niklas… - ERJ Open …, 2023 - Eur Respiratory Soc
Venous thromboembolism has been reported in patients with COVID-19. It remains unclear
if premorbid use of prophylactic oral anticoagulation, for reasons other than COVID-19 …
if premorbid use of prophylactic oral anticoagulation, for reasons other than COVID-19 …
Treatment with prophylactic oral anticoagulants and the risk of mortality in COVID-19 patients: a nationwide cohort study
S Altaraihi, P Kamstrup, J Eklöf… - ERJ open …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Venous thromboembolism has been reported in patients with coronavirus
disease 2019 (COVID-19). It remains unclear if premorbid use of prophylactic oral …
disease 2019 (COVID-19). It remains unclear if premorbid use of prophylactic oral …
Treatment with prophylactic oral anticoagulants and the risk of mortality in COVID-19 patients: a nationwide cohort study
S Altaraihi, P Kamstrup, J Eklöf… - ERJ Open …, 2023 - research.regionh.dk
BACKGROUND: Venous thromboembolism has been reported in patients with coronavirus
disease 2019 (COVID-19). It remains unclear if premorbid use of prophylactic oral …
disease 2019 (COVID-19). It remains unclear if premorbid use of prophylactic oral …
Treatment with prophylactic oral anticoagulants and the risk of mortality in COVID-19 patients: a nationwide cohort study.
S Altaraihi, P Kamstrup, J Eklöf… - ERJ Open …, 2023 - europepmc.org
Venous thromboembolism has been reported in patients with coronavirus disease 2019
(COVID-19). It remains unclear if premorbid use of prophylactic oral anticoagulation, for …
(COVID-19). It remains unclear if premorbid use of prophylactic oral anticoagulation, for …